With few treatments available to stop or reverse Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of walking back cognitive decline. Alzheimer’s cases are rising in the ...
Roche Holdings AG on Monday shared results from the phase 3 persevERA Breast Cancer study of giredestrant combined with palbociclib in advanced cancer patients. Trial Misses Primary Goal The trial ...
A younger person walks arm-in-arm with an older person at a care facility. (Geralt/Pixabay via Courthouse News) (CN) — Scientists at UC San Francisco and Gladstone Institutes have pinpointed two ...
Old drugs, new ideas. That’s one of the core drivers of using artificial intelligence (AI) for drug development. Researchers using complex AI-fueled methods are now taking aim at what has become a ...
A combination of two cancer drugs may provide a pathway to treat Alzheimer’s, according to a study published July 21 in Cell. Researchers from the University of California San Francisco developed and ...
Researchers are exploring cancer drugs as a potential treatment for Alzheimer's disease, a neurodegenerative disorder with ...
AstraZeneca has also filed an oral SERD, camizestrant, targeting use of the drug in patients with advanced HR-positive breast ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results